logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9433675 B1

PDFFull Text
Date of Patent:
Sep. 06, 2016

Filed:

May. 21, 2013

Combination therapy involving antibodies against claudin 18.2 for treatment of cancer

Applicants:

Ganymed Pharmaceuticals Ag, Mainz, DE;

Tron—translationale Onkologie an Der Universitätsmedizin Der Johannes Gutenberg-universität Mainz Gemeinnützige Gmbh, Mainz, DE;

Inventors:

Ugur Sahin, Mainz, DE;

Özlem Türeci, Mainz, DE;

Rita Mitnacht-Kraus, Friedberg, DE;

Stefan Denis Jacobs, Mainz-Kastel, DE;

Magdalena Jadwiga Utsch, Heidesheim am Rhein, DE;

Cornelia Adriana Maria Heinz, Dalheim, DE;

Christiane Regina Stadler, Bensheim, DE;

Assignees:

Ganymed Pharmaceuticals AG, Mainz, DE;

TRON—Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-Universitat Mainz Gemeinnutzige GmbH, Mainz, DE;

Attorney:

Neal, Gerber & Eisenberg LLP

Primary Examiner:

Shulamith H Shafer

Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61K 39/00 (2006.01); A01N 57/00 (2006.01); A01N 33/02 (2006.01); A01N 43/40 (2006.01); A61K 45/06 (2006.01); C07K 16/30 (2006.01); A61K 31/282 (2006.01); A61K 31/337 (2006.01); A61K 31/4375 (2006.01); A61K 31/513 (2006.01); A61K 31/519 (2006.01); A61K 31/675 (2006.01); A61K 31/704 (2006.01); A61K 33/24 (2006.01); A61K 38/20 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39558 (2013.01); A61K 31/282 (2013.01); A61K 31/337 (2013.01); A61K 31/4375 (2013.01); A61K 31/513 (2013.01); A61K 31/519 (2013.01); A61K 31/675 (2013.01); A61K 31/704 (2013.01); A61K 33/24 (2013.01); A61K 38/2013 (2013.01); A61K 45/06 (2013.01); C07K 16/3046 (2013.01); C07K 2317/73 (2013.01); C07K 2317/732 (2013.01); C07K 2317/734 (2013.01);
Abstract

The present invention provides a combination therapy for effectively treating and/or preventing diseases associated with cells expressing CLDN18.2, including cancer diseases such as gastric cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon cancer, hepatic cancer, head-neck cancer, and cancer of the gallbladder and metastases thereof.

Find Patent Forward Citations

Sahin, Ugur. (2016). Combination therapy involving antibodies against claudin 18.2 for treatment of cancer (U.S. Patent No. 9433675). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9433675

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…